Clinical Trial Update: Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of KDS2010 in adults with mild cognitive impairment and mild dementia due to Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Dementia Due to Alzheimer Disease

Drugs mentioned

• KDS2010

Snippet

Sponsor: NeuroBiogen Co., Ltd | Conditions: Mild Cognitive Impairment (MCI), Mild Dementia | Phase 2 | Status: RECRUITING